Comments
Eris Lifesciences on Wednesday said its board has approved buyback of shares worth up to Rs 100 crore. The buyback is for 17.39 lakh shares at Rs 575 apiece.
The promoters and promoter group of the drug firm have expressed their intention to not participate in the buyback, Eris Lifesciences said in a filing to BSE.
The 17.39 lakh shares constitute around 1.26 per cent of the total paid-up equity capital of the company, it added. Shares of Eris Lifesciences closed at Rs 496.50 per scrip on BSE, down 1.75 per cent from the previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.